Department of Hand Surgery, Honghui Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, 710054, China.
J Food Biochem. 2021 May;45(5):e13585. doi: 10.1111/jfbc.13585. Epub 2021 Apr 12.
This study evaluated the anti-inflammatory activity against lipopolysaccharide (LPS)-mediated mouse macrophages (in vitro) and assessed the protective effect of farrerol on arthritis caused by complete freund adjuvant (CFA) in rats. For the evaluation of the pharmacological effect of farrerol on the activity of nitric oxide (NO) and cyclooxygenase, pro-inflammatory cytokines including interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interleukin-1β, RAW 264.7 cells were used. A 0.1 ml CFA was injected subcutaneously for the induction of arthritis. The paw volume, body weight and arthritic score were estimated at regular intervals. Pro-inflammatory cytokines, inflammatory mediators, and antioxidant parameters were also estimated. Farrerol suppressed NO production and COX-catalyzed prostaglandin (PGE ) in RAW 264.7. Farrerol also downregulated the p-p65, p-IκBα expression and upregulated the PPAR-γ expression in RAW 264.7 cells. Treatment of farrerol increased body weight substantially, and reduced paw edema and arthritic score. Farrerol treatment also significantly improved the level of hemoglobin (Hb), count of red blood cells (RBC), and decreased the rate of erythrocyte sedimentation (ESR), white blood cell (WBC) parameters, while the generation of pro-inflammatory cytokines inhibited. Together, farrerol also suppressed the pro-inflammatory cytokines TNF-α, IL-6, and IL-1β. Obtained results directed that the farrerol exerted its therapeutic effect against CFA-induced arthritic rats through anti-inflammatory mechanism by regulation of the PPAR-γ. PRACTICAL APPLICATIONS: Increase the arthritis disease worldwide day-by-day. The current research study showed the anti-arthritic effect of farrerol (flavonoid phytoconstituent) of Rhododendron dauricum Linn. In this study, farrerol considerably inhibited the NF-κB to show the anti-arthritic effect. The finding showed the potential effect against acute and chronic inflammation via inhibition of inflammatory mediators and oxidative stress. The result suggests the anti-inflammatory and antioxidant effect of farrerol. On the basis of result, we can say that farrerol can be the beneficial drug to treat the arthritis.
本研究评估了法乐醇对脂多糖(LPS)介导的小鼠巨噬细胞(体外)的抗炎活性,并评估了法乐醇对完全弗氏佐剂(CFA)诱导的大鼠关节炎的保护作用。为了评估法乐醇对一氧化氮(NO)和环氧化酶活性的药理作用,使用了 RAW 264.7 细胞来评估包括白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)和白细胞介素-1β在内的促炎细胞因子。通过皮下注射 0.1 ml CFA 诱导关节炎。定期评估爪体积、体重和关节炎评分。还估计了促炎细胞因子、炎症介质和抗氧化参数。法乐醇抑制了 RAW 264.7 中 NO 的产生和 COX 催化的前列腺素(PGE )。法乐醇还下调了 RAW 264.7 细胞中的 p-p65、p-IκBα 表达,并上调了 PPAR-γ 表达。法乐醇治疗显著增加了体重,减少了爪水肿和关节炎评分。法乐醇治疗还显著提高了血红蛋白(Hb)水平、红细胞(RBC)计数,降低了红细胞沉降率(ESR)、白细胞(WBC)参数,同时抑制了促炎细胞因子的产生。总之,法乐醇还抑制了促炎细胞因子 TNF-α、IL-6 和 IL-1β。结果表明,法乐醇通过调节 PPAR-γ,通过抗炎机制对 CFA 诱导的关节炎大鼠发挥治疗作用。
关节炎疾病在全球范围内日益增多。本研究表明,Rhododendron dauricum Linn 的法乐醇(类黄酮植物成分)具有抗关节炎作用。在这项研究中,法乐醇显著抑制了 NF-κB 以显示出抗关节炎作用。研究结果表明,通过抑制炎症介质和氧化应激,法乐醇具有潜在的抗急性和慢性炎症作用。该结果表明了法乐醇的抗炎和抗氧化作用。基于研究结果,我们可以说法乐醇可以成为治疗关节炎的有益药物。